0
Letters |

Pediatric Horner Syndrome—Reply

Stephen J. Smith, BS; Brian G. Mohney, MD
[+] Author Affiliations

Author Affiliations: Mayo Clinic College of Medicine (Dr Smith), and Department of Ophthalmology (Dr Mohney), Mayo Clinic and Mayo Foundation, Rochester, Minnesota.


Arch Ophthalmol. 2011;129(8):1108-1109. doi:10.1001/archophthalmol.2011.202
Text Size: A A A
Published online

In reply

We wish to thank Liu and colleagues for their interest in our article on the incidence of pediatric Horner syndrome and risk of neuroblastoma.1 We assume that issues regarding our methodology stem from the inherent limitations of retrospective clinical studies. However, our methodology was both clearly described and consistent, and therefore does not affect the validity of our findings.

Our results, and those of other studies,2 4 suggest that obtaining imaging studies should not be considered the standard of care for pediatric patients with Horner syndrome manifesting at, or shortly after, documented trauma. Specifically, children whose syndrome appears following birth or other trauma, in addition to surgical trauma, do not need imaging studies, unless physical examination findings detect syndrome worsening.

In our cohort, a malignant tumor could not be definitively excluded in the 7 idiopathic cases and the 7 cases attributed to birth trauma; however, these cases had a mean follow-up of 68 months without the identification of an underlying mass lesion. The percentage of patients with idiopathic Horner syndrome who are found to have a previously undetected neuroblastoma5 6 or other malignancy is small,7 and the decision to subject all such children to imaging should be made with consideration for the potential drawbacks of imaging studies, including the risks of general anesthesia and radiation exposure.

In their letter, Liu and coauthors state that their study7 was free of referral bias because patients came to them without a prior diagnosis or evaluation. However, their population comprised those presenting to a tertiary care center and is therefore potentially biased toward children with more severe disease, unlike the population-based confines of the children residing in Olmsted County, Minnesota.

Finally, while many parents may desire imaging for their child when presented with the possibility of an underlying neoplasm, this was not universally the case in the study by Mahoney and coauthors,7 in which “some patients and parents refused” imaging studies. The findings of our study and others support our recommendation that a more judicious approach be used when approaching pediatric patients with Horner syndrome.2 4

AUTHOR INFORMATION

Correspondence: Dr Mohney, Department of Ophthalmology, Mayo Clinic, 200 First St SW, Rochester, MN 55905 (mohney@mayo.edu).

Financial Disclosure: None reported.

REFERENCES

Smith SJ, Diehl N, Leavitt JA, Mohney BG. Incidence of pediatric Horner syndrome and the risk of neuroblastoma: a population-based study.  Arch Ophthalmol. 2010;128(3):324-329
PubMedCrossRef
Giles CL, Henderson JW. Horner's syndrome: an analysis of 216 cases.  Am J Ophthalmol. 1958;46(3, part 1):289-296
PubMed
Weinstein JM, Zweifel TJ, Thompson HS. Congenital Horner's syndrome.  Arch Ophthalmol. 1980;98(6):1074-1078
PubMedCrossRef
George NDL, Gonzalez G, Hoyt CS. Does Horner's syndrome in infancy require investigation?  Br J Ophthalmol. 1998;82(1):51-54
PubMedCrossRef
Musarella MA, Chan HS, DeBoer G, Gallie BL. Ocular involvement in neuroblastoma: prognostic implications.  Ophthalmology. 1984;91(8):936-940
PubMed
Jaffe N, Cassady R, Petersen R, Traggis D. Heterochromia and Horner syndrome associated with cervical and mediastinal neuroblastoma.  J Pediatr. 1975;87(1):75-77
PubMedCrossRef
Mahoney NR, Liu GT, Menacker SJ, Wilson MC, Hogarty MD, Maris JM. Pediatric Horner syndrome: etiologies and roles of imaging and urine studies to detect neuroblastoma and other responsible mass lesions.  Am J Ophthalmol. 2006;142(4):651-659
PubMedCrossRef

First Page Preview

First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Smith SJ, Diehl N, Leavitt JA, Mohney BG. Incidence of pediatric Horner syndrome and the risk of neuroblastoma: a population-based study.  Arch Ophthalmol. 2010;128(3):324-329
PubMedCrossRef
Giles CL, Henderson JW. Horner's syndrome: an analysis of 216 cases.  Am J Ophthalmol. 1958;46(3, part 1):289-296
PubMed
Weinstein JM, Zweifel TJ, Thompson HS. Congenital Horner's syndrome.  Arch Ophthalmol. 1980;98(6):1074-1078
PubMedCrossRef
George NDL, Gonzalez G, Hoyt CS. Does Horner's syndrome in infancy require investigation?  Br J Ophthalmol. 1998;82(1):51-54
PubMedCrossRef
Musarella MA, Chan HS, DeBoer G, Gallie BL. Ocular involvement in neuroblastoma: prognostic implications.  Ophthalmology. 1984;91(8):936-940
PubMed
Jaffe N, Cassady R, Petersen R, Traggis D. Heterochromia and Horner syndrome associated with cervical and mediastinal neuroblastoma.  J Pediatr. 1975;87(1):75-77
PubMedCrossRef
Mahoney NR, Liu GT, Menacker SJ, Wilson MC, Hogarty MD, Maris JM. Pediatric Horner syndrome: etiologies and roles of imaging and urine studies to detect neuroblastoma and other responsible mass lesions.  Am J Ophthalmol. 2006;142(4):651-659
PubMedCrossRef

Correspondence

August 1, 2011
Stephen J. Smith, BS; Brian G. Mohney, MD
Arch Ophthalmol. 2011;129(8):1108-1109. doi:10.1001/archophthalmol.2011.202.
August 1, 2011
Grant T. Liu, MD; Nicholas R. Mahoney, MD; Robert A. Avery, DO; Sheryl J. Menacker, MD; Martin C. Wilson, MD; Michael D. Hogarty, MD; John M. Maris, MD
Arch Ophthalmol. 2011;129(8):1108-1109. doi:10.1001/archophthalmol.2011.201.
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.